Impact of chromogranin A measurement in the work-up of neuroendocrine tumors

By Baudin E.   Bidart J.   Bachelot A.   Ducreux M.   Elias D.   Ruffié P.   Schlumberger M.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 79-82

Springer Publishing Company

Access to resources Recommend Favorite

Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience

By Stivanello M.   Berruti A.   Torta M.   Termine A.   Tampellini M.   Gorzegno G.   Angeli A.   Dogliotti L.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 73-77

Springer Publishing Company

Access to resources Recommend Favorite

Commentary to “Chromogranin A: Biological Function and Clinical Utility in Neuroendocrine Tumor Disease”

By Jeske Wojciech  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 293-293

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of neuroendocrine carcinoma of the breast

By Sapino A.   Papotti M.   Righi L.   Cassoni P.   Chiusa L.   Bussolati G.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 115-117

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer

By Carnaghi C.   Rimassa L.   Garassino I.   Santoro A.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite